[1] Mermel L A, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection:2009 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2009, 49(1):1-45. [2] Marik P E, Flemmer M, Harrison W. The risk of catheter-related blood-stream infection with femoral venous catheters as compared to subclavian an internal jugular venous catheters:A systematic review of the literature and meta-analysis[J]. Crit Care Med, 2012, 40(8):2479-2485. [3] Vallés J, Ferrer R. Bloodstream infection in the ICU[J]. Infect Dis Clin North Am, 2009, 23(3):557-569. [4] Hina H, McDowell J. Minimising central line associated bloodstream infection (CLABSIs) rate in inserting central venous catheters (CVCs) in the Adult Intensive Care Unit (ACIUs)[J]. J Clin Nurs, 2017,26(23-24):3962-3973. [5] Ge X, Cavallazzi R, Li C, et al. Central venous access sites for the prevention of venous thrombosis, stenosis and infection[J]. Cochrane Database Syst Rev, 2012,2012(3):CD004084. [6] 孙福月,王国力,李霞,等. ICU外周静脉导管留置时间对导管相关性血流感染影响的研究[J].中国实用护理杂志, 2018, 34(15):1133-1136. [7] 葛学顺,陈维开,蒋福云,等.集束化干预策略在预防ICU中心静脉导管相关性血流感染中的应用[J].中国感染控制杂志, 2012, 11(6):422-424. [8] Sordé R, Almirante B, Palomar M, et al. Comment on:Changing epidemiology of central venous catheter-related bloodstream infections:increasing prevalence of Gram-negative pathogens[J]. Antimicrob Chemother, 2012, 67(6):1565-1567. [9] 陶真,夏优秀,林小玲. 2509例医院感染调查分析[J].中华医院感染学杂志, 2011, 21(10):4016-4018. [10] 范润平,龚青霞,巩文花,等. ICU患者中心静脉导管血流感染危险因素的Meta分析[J].中国感染控制杂志, 2018, 17(4):335-340. [11] 王敏,杨昕,周燕平,等. ICU患者深静脉导管留置时间与导管相关血流感染的关系研究[J].检验医学与临床, 2019, 16(12):1763-1766. [12] Marik P E, Flemmer M, Harrison W. The risk of catheter-related bloodstream infection with femoral venous catheters as compared to subclavian and internal jugular venous catheters:a systematic review of the literature and meta-analysis[J]. Crit Care Med, 2012, 40(8):2479-2485. [13] 陶真,林小玲,甘文思,等.中心静脉导管相关性血流感染的临床及病原学的回顾性调查分析[J].医学研究杂志, 2017, 46(5):159-163. [14] Parienti J J, Cheyron D, Timsit J F, et al. Meta-analysis of subclavian insertion and nontunneled central venous catheter-associated infection risk reduction in critically ill adults[J]. Crit Care Med, 2012, 40(5):1627-1634. [15] 敬雪明,李铃,古雪,等.恶性血液病患者导管相关血流感染的临床特点及危险因素分析[J].中国现代医学杂志, 2016, 26(1):119-123. [16] Cheng S, Xu S, Guo J, et al. Risk factors of centraI venous catheter-related bloodstream infection for continuous renal replacement therapy in kidney intensive care unit patients[J]. Blood Purif, 2019, 48(2):175-182. [17] 陈玲,常为民,赵凤娟. ICU内中心静脉导管相关性血流感染的调查及危险因素分析[J].河北医药, 2016, 38(4):542-544. [18] 温妙云,曾红科,黄伟平,等.重症监护病房感染患者细菌分布及耐药性分析[J].中华危重病急救医学, 2013, 25(4):215-218. [19] 范亚霞,张嫘,邢欢,等. 2015-2017年我院神经重症科及部分科室多重耐药菌变化情况分析[J].中国煤炭工业医学杂志,2018,21(4):416-419. [20] Pittet D, Li N, Wenzel R P. Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality[J]. Eur J Clin Microbiol Infect Dis, 1993, 12(11):813-819. [21] O'Grady N P, Alexander M, Burns L A, et al. Guidelines for the prevention of intravascular catheter-related infections[J]. Am J Infect Control, 2011, 39(4 Suppl 1):S1-34. [22] 赵青兰,陈梅英.腔内心电图引导经外周中心静脉置管尖端定位的研究进展[J].临床误诊误治,2019,32(11):102-106. [23] 艾山木,蒋东坡.中央导管相关血流感染"零容忍"的实践[J].肠外与肠内营养, 2017, 24(3):132-134. |